These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 21653254)

  • 1. Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers.
    Makawita S; Smith C; Batruch I; Zheng Y; Rückert F; Grützmann R; Pilarsky C; Gallinger S; Diamandis EP
    Mol Cell Proteomics; 2011 Oct; 10(10):M111.008599. PubMed ID: 21653254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9.
    Makawita S; Dimitromanolakis A; Soosaipillai A; Soleas I; Chan A; Gallinger S; Haun RS; Blasutig IM; Diamandis EP
    BMC Cancer; 2013 Sep; 13():404. PubMed ID: 24007603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients.
    Tian M; Cui YZ; Song GH; Zong MJ; Zhou XY; Chen Y; Han JX
    BMC Cancer; 2008 Aug; 8():241. PubMed ID: 18706098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive proteomic analysis of human pancreatic juice.
    Grønborg M; Bunkenborg J; Kristiansen TZ; Jensen ON; Yeo CJ; Hruban RH; Maitra A; Goggins MG; Pandey A
    J Proteome Res; 2004; 3(5):1042-55. PubMed ID: 15473694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia.
    Chen R; Pan S; Duan X; Nelson BH; Sahota RA; de Rham S; Kozarek RA; McIntosh M; Brentnall TA
    Mol Cancer; 2010 Jun; 9():149. PubMed ID: 20550709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of pancreatic juice proteins as biomarkers of pancreatic cancer.
    Gao J; Zhu F; Lv S; Li Z; Ling Z; Gong Y; Jie C; Ma L
    Oncol Rep; 2010 Jun; 23(6):1683-92. PubMed ID: 20428826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and proteomic characterization of extracellular vesicles in human pancreatic juice.
    Osteikoetxea X; Benke M; Rodriguez M; Pálóczi K; Sódar BW; Szvicsek Z; Szabó-Taylor K; Vukman KV; Kittel Á; Wiener Z; Vékey K; Harsányi L; Szűcs Á; Turiák L; Buzás EI
    Biochem Biophys Res Commun; 2018 Apr; 499(1):37-43. PubMed ID: 29550476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative proteomic profiling of pancreatic ductal adenocarcinoma cell lines.
    Kim Y; Han D; Min H; Jin J; Yi EC; Kim Y
    Mol Cells; 2014 Dec; 37(12):888-98. PubMed ID: 25518923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA expression analyses in preoperative pancreatic juice samples of pancreatic ductal adenocarcinoma.
    Sadakari Y; Ohtsuka T; Ohuchida K; Tsutsumi K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    JOP; 2010 Nov; 11(6):587-92. PubMed ID: 21068491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines.
    Planque C; Kulasingam V; Smith CR; Reckamp K; Goodglick L; Diamandis EP
    Mol Cell Proteomics; 2009 Dec; 8(12):2746-58. PubMed ID: 19776420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
    Ohuchida K; Mizumoto K; Fujita H; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2006 Sep; 210(1):42-8. PubMed ID: 16794990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers.
    Karagiannis GS; Pavlou MP; Saraon P; Musrap N; Xie A; Batruch I; Prassas I; Dimitromanolakis A; Petraki C; Diamandis EP
    J Proteomics; 2014 May; 103():121-36. PubMed ID: 24681409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of indicator genes using global complementary DNA (cDNA) amplification, by polyadenylic acid reverse transcriptase polymerase chain reaction (poly A RT-PCR): A feasibility study using paired samples from tissue and ductal juice in patients undergoing pancreatoduodenectomy.
    Sanyal S; Siriwardena AK; Byers R
    Pancreatology; 2018 Jun; 18(4):458-462. PubMed ID: 29574096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.
    Rosty C; Christa L; Kuzdzal S; Baldwin WM; Zahurak ML; Carnot F; Chan DW; Canto M; Lillemoe KD; Cameron JL; Yeo CJ; Hruban RH; Goggins M
    Cancer Res; 2002 Mar; 62(6):1868-75. PubMed ID: 11912167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags.
    Sogawa K; Takano S; Iida F; Satoh M; Tsuchida S; Kawashima Y; Yoshitomi H; Sanda A; Kodera Y; Takizawa H; Mikata R; Ohtsuka M; Shimizu H; Miyazaki M; Yokosuka O; Nomura F
    Br J Cancer; 2016 Oct; 115(8):949-956. PubMed ID: 27657339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach.
    Grønborg M; Kristiansen TZ; Iwahori A; Chang R; Reddy R; Sato N; Molina H; Jensen ON; Hruban RH; Goggins MG; Maitra A; Pandey A
    Mol Cell Proteomics; 2006 Jan; 5(1):157-71. PubMed ID: 16215274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma.
    Nakamura S; Sadakari Y; Ohtsuka T; Okayama T; Nakashima Y; Gotoh Y; Saeki K; Mori Y; Nakata K; Miyasaka Y; Onishi H; Oda Y; Goggins M; Nakamura M
    Ann Surg Oncol; 2019 Jul; 26(7):2104-2111. PubMed ID: 30820789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation.
    Sitek B; Sipos B; Alkatout I; Poschmann G; Stephan C; Schulenborg T; Marcus K; Lüttges J; Dittert DD; Baretton G; Schmiegel W; Hahn SA; Klöppel G; Meyer HE; Stühler K
    J Proteome Res; 2009 Apr; 8(4):1647-56. PubMed ID: 19714807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoassay-based proteome profiling of 24 pancreatic cancer cell lines.
    Alhamdani MS; Youns M; Buchholz M; Gress TM; Beckers MC; Maréchal D; Bauer A; Schröder C; Hoheisel JD
    J Proteomics; 2012 Jun; 75(12):3747-59. PubMed ID: 22579748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.